US rural hospital closures threaten cancer screening and patient care

US rural hospital closures threaten cancer screening and patient care

The infrastructure of American rural healthcare is fracturing, creating a "domino effect" of barriers for cancer patients that extends from the first screening to the final stage of treatment. Recent data reveals a deepening crisis in access, as hundreds of rural hospitals have vanished or are currently at risk of closing, stripping underserved communities of essential diagnostic and therapeutic services.

According to the Sheps Center at the University of North Carolina, 195 rural hospitals have either closed or converted away from traditional inpatient services since 2005. Other data indicates that 177 rural hospitals have closed nationwide, with more than 400 remaining at risk as of 2026. Further analyses suggest the crisis is even broader, with 720 rural hospitals considered at risk of closure due to severe financial distress.

The Erosion of the Cancer Care Pathway

While public discourse often centers on the loss of emergency departments or maternity wards, the impact on oncology is profound. Rural hospitals often serve as the foundational entry point for cancer care, providing the mammography, CT imaging, biopsies, and lung cancer screenings necessary for early detection. When these facilities close, patients face longer travel distances and delays in diagnostic testing.

For many, these delays translate into more advanced disease at the time of presentation. Patients who once traveled 20 minutes for a scan may find themselves driving 90 minutes or more, a burden that often becomes insurmountable for elderly patients or those with limited transportation.

The loss of chemotherapy services is equally stark. Brock Slabach of the National Rural Health Association stated that 448 rural hospitals have stopped offering chemo services and that 22% of rural hospitals that offered chemotherapy in 2014 no longer provide it.

Radiation Oncology: A Geographic Crisis

Radiation therapy presents a unique challenge because it cannot be delivered via telehealth; it requires specialized equipment and daily physical visits. A study published in the International Journal of Radiation Oncology, Biology, Physics, examined sites between 2018 and 2025, finding that rural sites had 44% higher odds of disappearance than urban ones. Freestanding sites were also 56% more likely to disappear than hospital-affiliated facilities.

The resulting geographic disparity is severe:

By 2025, 68.5% of all U.S. Counties—2,154 out of 3,144—had no radiation oncology practice site, affecting approximately 50.8 million people. These areas typically correlate with higher poverty rates and lower median household incomes.

Financial Instability and Systemic Barriers

The closures are driven by sustained operating losses and inadequate reimbursement. According to Slabach, 40% of rural hospitals are operating in a negative capacity. Many rely on unstable local tax support or state subsidies, and some depend on the 340B Drug Pricing Program to subsidize pharmacy operations and patient navigation.

Insurance design also plays a role. Slabach noted that Medicare Advantage plans can shift patients away from traditional Medicare protections, such as low-volume hospital programs, reducing revenue predictability for rural facilities.

These systemic failures place a heavy burden on patients and community oncology practices. Manali Patel, MD of Stanford Medicine, observed that rural survivors are more likely to experience financial problems related to cancer than urban survivors. These stressors lead some patients to skip medical visits or forego medications. Dr. Patel noted that distance traveled to receive care is reliant on time off from work which further compounds impact on income and financial hardship.

Paths to Preservation

Healthcare providers are exploring several interventions to bridge the gap. The Veterans Affairs (VA) has implemented the National TeleOncology Program and the "Close-to-Me" program, which allows veterans to receive specialist care via telemedicine while accessing community-based infusions. Other models, such as Project ECHO, use a "spoke and hub" system to partner rural clinicians with academic specialists.

Technological integration is also being leveraged. Bridge Oncology is deploying AI-enabled workflow orchestration and wearable technology to monitor symptoms and treatment tolerance remotely, reducing the need for unnecessary emergency department visits.

However, experts argue that technology alone is insufficient. There is a growing call for payment reform, such as the MASON model, which recognizes the intrinsic value of maintaining access in remote communities regardless of patient volume. Slabach added that the industry will be watching the next five years closely as states implement the Rural Health Transformation Program under H.R.1 to see if scalable best practices emerge.